ArticleBioMed research international2022

Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and

Farnosh Darabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.